Literature DB >> 1085289

Inflammatory cells in solid murine neoplasms. II. Cell types found throughout the course of Moloney sarcoma regression or progression.

S W Russell, G Y Gillespie, C B Hansen, C G Cochrane.   

Abstract

Regressing and progressing Moloney sarcomas, induced in BALB/c mice by the injection of cultured sarcoma cells (MSC)1, were sampled for histologic analysis and then disaggregated using mixtures of trypsin, collagenase and DNAse or collagenase and DNAse alone. The types of inflammatory cells (IC) found in resultant cell suspensions were determined 6, 11, 14 and 18 days post inoculation. Inflammatory infiltrates were composed almost exclusively of three cell types; neutrophils, T lymphocytes and macrophages. The extent to which each was found in tumors was related to the time post inoculation. Neutrophils were part of an early acute inflammatory response seen in both developing regressing and progressing sarcomas. The onset of regression was associated histologically with the appearance within tumors of a mononuclear inflammatory infiltrate. T lymphocytes and macrophages were the principal constituents. A higher percentage of T lymphocytes was recovered at all sampling times from regressing, compared to progressing, sarcomas. During development of the mononuclear inflammatory infiltrate there were relatively more large T cells in regressing, than in progressing tumors, and the percentage of macrophages was higher. Thereafter, the proportion of macrophages in the recovered cell population was approximately the same for both types of tumor. Such equality was more apparent than real, however, since IC were restricted to the peripheries of progressing sarcomas after the acute inflammatory phase, but continued to be found throughout regressing neoplasms. The effective ratio of macrophages and T lymphocytes to tumor cells therefore was much lower in progressing sarcomas than was suggested by percentage figures. The data presented support the concept that T lymphocytes are instrumental in causing the regression of Moloney sarcomas, possibly through interactions with macrophages.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1085289     DOI: 10.1002/ijc.2910180310

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  17 in total

1.  Studies on inflammatory response induced by Ehrlich tumor in mice peritoneal cavity.

Authors:  D Fecchio; P Sirois; M Russo; S Jancar
Journal:  Inflammation       Date:  1990-02       Impact factor: 4.092

2.  Surface markers of small lymphocytes appearing in the mouse Ehrlich ascites tumour, host spleen and blood.

Authors:  S Garnis; P K Lala
Journal:  Immunology       Date:  1978-03       Impact factor: 7.397

Review 3.  Relationship of tumor leucocytic infiltration to host defense mechanisms and prognosis.

Authors:  J W Kreider; G L Bartlett; B L Butkiewicz
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

4.  Histopathology and host response associated with reduced tumorigenicity of 5-bromodeoxyuridine--treated murine melanoma cells.

Authors:  K K Gyi; J R Wrathall
Journal:  Am J Pathol       Date:  1983-02       Impact factor: 4.307

5.  Decreased monocyte-mediated cytostasis of human cancer cell in patients with lung cancer.

Authors:  Y Nakata; J Yamashita; T Kishi; M Kataoka; T Ejiri; T Ohnoshi; I Kimura
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

6.  Membranes from T and B lymphocytes have different patterns of tyrosine phosphorylation.

Authors:  H S Earp; K S Austin; S C Buessow; R Dy; G Y Gillespie
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

7.  Cathepsin G induces cell aggregation of human breast cancer MCF-7 cells via a 2-step mechanism: catalytic site-independent binding to the cell surface and enzymatic activity-dependent induction of the cell aggregation.

Authors:  Riyo Morimoto-Kamata; Sei-ichiro Mizoguchi; Takeo Ichisugi; Satoru Yui
Journal:  Mediators Inflamm       Date:  2012-07-08       Impact factor: 4.711

8.  Tumors induced by murine sarcoma virus contain precursor cells capable of generating tumor-specific cytolytic T lymphocytes.

Authors:  J M Chapdelaine; F Plata; F Lilly
Journal:  J Exp Med       Date:  1979-06-01       Impact factor: 14.307

9.  Response of tumour-related and normal lymphocytes to antigens on fibroblasts from embryos of varying age.

Authors:  R M Gorczynski
Journal:  Br J Cancer       Date:  1978-05       Impact factor: 7.640

10.  Resurgence of killing and in vivo protection mediated by lymphocytes cultured from lymph nodes draining Moloney sarcomas.

Authors:  G Y Gillespie; C B Hansen; S W Russell
Journal:  Br J Cancer       Date:  1978-09       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.